Among 70- to 79-year-old men, for example, those with three or four of the aging signs had a 44% absolute 10-year risk of ischemic heart disease
, whereas those with none of the four signs had a 32% risk.
Among men aged 70- 79, for example, those with three or four of the aging signs had a 44% absolute 10-year risk of ischemic heart disease
, while those with none of the signs had a 32% risk.
Luke's Episcopal Hospital, Houston and colleagues conducted a study to examine the effect of transendocardial administration (use of a special catheter and injection procedure to deliver stem cells to the heart muscle) of BMCs to patients with chronic ischemic heart disease
and left ventricular (LV) dysfunction with heart failure and/or angina.
The combination of all three of the complications increased by sevenfold a woman's risk of being admitted to the hospital for ischemic heart disease
or of dying from the disease later in life, compared with other first-time mothers who were delivered without any of these complications (Lancet 357:2002-06, 2001).
We found the highest risk of death during the first week of quinine treatment in patients with ischemic heart disease
and on a beta-blocker, but if quinine was used chronically it still increased the risk.
In a review of the medical records of 4,735 patients across the United Kingdom, levothyroxine therapy reduced all-cause mortality and the number of ischemic heart disease
events in adults up to 70 years of age, but did not benefit those older than 70, said Dr.
Is this increase in ischemic heart disease
due to traditional risk factors, or is psoriasis an additional independent risk factor?
between 1998 and 2008 to evaluate the validity of the Framingham Risk Score in predicting the incidence of ischemic heart disease
in the study cohort.
During follow-up, both fatal and nonfatal ischemic heart disease
events occurred in 165 patients in the younger group (5.
suggest that xanthelasmata are a cutaneous marker of atherosderosis independent of lipid concentrations and thus should be considered in clinical practice as an independent and additional risk factor for myocardial infarction and ischemic heart disease
," wrote Mette Christoffersen and her coauthors (BMJ 2011;343:d5497).
The Lumenair([TM]) EECP([R])Therapy System is the latest of Vasomedical's products for the treatment of patients with ischemic heart disease
The results from this study surest that xanthelasmata are a cutaneous marker of atherosclerosis independent of lipid concentrations and thus should be considered in clinical practice as an independent and additional risk factor for myocardial infarction and ischemic heart disease
," Mette Christoffersen and her coinvestigators wrote in a study published online (BMJ 2011;343:d5497).